ECRI Institute today identified surgical stapler misuse as the leading health technology safety concern. In March, the Food and Drug Administration issued recommendations for health care providers to reduce the risk of adverse events associated with surgical staplers and staples for internal use. ECRI said other leading health technology risks include: point-of-care ultrasound; sterile processing in medical and dental offices; hemodialysis with central venous catheters; unproven surgical robotic procedures; alarm, alert and notification overload; cybersecurity in the connected home health care environment; missing patient implant data for magnetic resonance imaging; medication dose timing discrepancies in electronic health records; and loose medical device components. 

Headline
The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus…
Headline
Thomas McGinn, M.D., senior executive vice president and chief physician executive officer at CommonSpirit Health, shares how the organization aligns…
Headline
The Food and Drug Administration Feb. 3 released an early alert on a heart pump issue from certain Abiomed products. The agency said Abiomed found its Impella…
Headline
Stephanie Calcasola, R.N., chief quality officer and vice president of quality and safety at Hartford HealthCare, unpacks the programs, technology and cultural…
Headline
Wendy Kim, DNP, R.N., vice president and chief nursing officer of Henry Ford Health in Michigan, shares how the system’s virtual nursing program is reducing…
Headline
The Food and Drug Administration has identified a recall by Cook Medical of Zenith Alpha 2 Thoracic Endovascular Graft proximal components after Cook Medical…